PMID- 38003970 OWN - NLM STAT- MEDLINE DCOM- 20231127 LR - 20231127 IS - 1648-9144 (Electronic) IS - 1010-660X (Print) IS - 1010-660X (Linking) VI - 59 IP - 11 DP - 2023 Oct 30 TI - Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and the Risk of Developing Incidental Tuberculosis: A Population-Based Cohort Study. LID - 10.3390/medicina59111920 [doi] LID - 1920 AB - Background and Objectives: Treatment for antineutrophil cytoplasmic antibody-associated vasculitis (AAV) must deal with immunosuppression, as well as infections associated with a compromised immune system, such as tuberculosis (TB). Our aim was to examine the risk of incidental TB after diagnosis of AAV. Materials and Methods: This retrospective population-based cohort study was based on the data from the National Health Insurance Research Database in Taiwan. Patients with newly diagnosed granulomatous polyangiitis or microscopic polyangiitis were identified between 1 January 2000 and 31 December 2012. The primary outcome was risk of incidental TB. Cox proportional hazard models were used to evaluate the association between AAV and incidental TB. Results: A total of 2257 patients with AAV and a propensity-score matched cohort of 9028 patients were studied. Overall, patients with AAV were at a 1.48x higher risk of contracting incidental TB than the patients in the matched cohort (adjusted HR 1.48; 95% confidence interval [CI], 1.02-2.15). Note that the highest risk of contracting incidental TB was in the first two years following a diagnosis of AAV, with a nearly 1-fold increase in risk (adjusted HR, 1.91; 95% CI, 1.01-3.60). Female AAV patients were 3.24x more likely than females without AAV to develop TB (adjusted HR 3.24; 95% CI, 1.85-5.67). Conclusions: Patients with AAV exhibit a 48% elevated TB risk, notably, a 91% increase within the first two years postdiagnosis. Female AAV patients face a 3.24 times higher TB risk compared to females without AAV. This study is limited by potential misclassification and overestimation of AAV cases. Clinicians should closely monitor TB risk in AAV patients, especially in females and the initial two years following diagnosis. FAU - Chan, Shan-Ho AU - Chan SH AUID- ORCID: 0000-0002-8538-1046 AD - Department of Medical Imaging and Radiology, Shu-Zen Junior College of Medicine and Management, Kaohsiung 82144, Taiwan. FAU - Li, Ming-Feng AU - Li MF AUID- ORCID: 0000-0003-3472-9070 AD - Department of Medical Imaging and Radiology, Shu-Zen Junior College of Medicine and Management, Kaohsiung 82144, Taiwan. AD - Department of Radiology, Kaohsiung Veteran General Hospital, Kaohsiung 813414, Taiwan. FAU - Ou, Shih-Hsiang AU - Ou SH AD - Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan. AD - School of Nursing, Meiho University, Pingtung 91202, Taiwan. FAU - Lin, Mei-Chen AU - Lin MC AD - Management Office for Health Data, China Medical University Hospital, Taichung 404327, Taiwan. AD - College of Medicine, China Medical University, Taichung 40402, Taiwan. FAU - Wang, Jen-Hung AU - Wang JH AUID- ORCID: 0000-0002-4946-8064 AD - Department of Medical Research, Hualien Buddhist Tzu-Chi General Hospital, Hualien 970473, Taiwan. FAU - Lee, Po-Tsang AU - Lee PT AD - Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan. AD - School of Nursing, Meiho University, Pingtung 91202, Taiwan. FAU - Chen, Hsin-Yu AU - Chen HY AUID- ORCID: 0000-0003-2093-0291 AD - Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan. AD - School of Nursing, Meiho University, Pingtung 91202, Taiwan. LA - eng PT - Journal Article DEP - 20231030 PL - Switzerland TA - Medicina (Kaunas) JT - Medicina (Kaunas, Lithuania) JID - 9425208 RN - 0 (Antibodies, Antineutrophil Cytoplasmic) SB - IM MH - Humans MH - Female MH - *Granulomatosis with Polyangiitis/diagnosis MH - Antibodies, Antineutrophil Cytoplasmic MH - Retrospective Studies MH - Cohort Studies MH - *Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications/epidemiology MH - *Tuberculosis/epidemiology PMC - PMC10673265 OTO - NOTNLM OT - antineutrophil cytoplasmic antibody-associated vasculitis OT - population-based study OT - tuberculosis COIS- The authors declare no conflict of interest. EDAT- 2023/11/25 12:45 MHDA- 2023/11/27 12:42 PMCR- 2023/10/30 CRDT- 2023/11/25 01:19 PHST- 2023/10/07 00:00 [received] PHST- 2023/10/22 00:00 [revised] PHST- 2023/10/26 00:00 [accepted] PHST- 2023/11/27 12:42 [medline] PHST- 2023/11/25 12:45 [pubmed] PHST- 2023/11/25 01:19 [entrez] PHST- 2023/10/30 00:00 [pmc-release] AID - medicina59111920 [pii] AID - medicina-59-01920 [pii] AID - 10.3390/medicina59111920 [doi] PST - epublish SO - Medicina (Kaunas). 2023 Oct 30;59(11):1920. doi: 10.3390/medicina59111920.